Physician

Nurul Abul Wahid, M.D.

According to 2025 Medicare claims, Nurul Wahid, M.D. (NPI: 1508808619) practices hematology/oncology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78503-1271.

Wahid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 263 traditional Medicare patients, billed 32,558 HCPCS/CPT codes, and received $620,441 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 466 prescription claims across 111 beneficiaries totaling $1,583,267 in drug costs, led by Revlimid (Lenalidomide). 2018 DME data shows 11 claims. Open Payments data shows 29 records totaling $509,149. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $554,725 and ending at $620,441. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,001,507 to $1,583,267. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$407K$813K2015 Medicare payment: $554,725 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $683,207 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $574,286 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $813,199 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $630,054 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $796,846 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $480,678 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $397,705 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $408,927 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $620,441 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201535549,444$554,725
201653552,804$683,207
201755149,861$574,286
201856768,645$813,199
201948656,869$630,054
202044255,974$796,846
202130227,800$480,678
202230437,631$397,705
202327628,844$408,927
202426332,558$620,441

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.7M2015 Drug cost: $1,001,507 (USD; Tot_Drug_Cst)2016 Drug cost: $1,012,207 (USD; Tot_Drug_Cst)2017 Drug cost: $1,026,017 (USD; Tot_Drug_Cst)2018 Drug cost: $1,403,264 (USD; Tot_Drug_Cst)2019 Drug cost: $1,761,418 (USD; Tot_Drug_Cst)2020 Drug cost: $1,970,210 (USD; Tot_Drug_Cst)2021 Drug cost: $1,592,504 (USD; Tot_Drug_Cst)2022 Drug cost: $2,507,715 (USD; Tot_Drug_Cst)2023 Drug cost: $2,680,464 (USD; Tot_Drug_Cst)2024 Drug cost: $1,583,267 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015121448$1,001,507
2016103487$1,012,207
2017101511$1,026,017
2018116495$1,403,264
2019104468$1,761,418
202098574$1,970,210
202196556$1,592,504
202282530$2,507,715
2023105495$2,680,464
2024111466$1,583,267

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$77$1532018 Medicare payment: $153 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R11$153
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more117315$86
80053Blood test, comprehensive group of blood chemicals102298$10
36415Insertion of needle into vein for collection of blood sample104366$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count106361$7
83615Lactate dehydrogenase (enzyme) level79144$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide21590$355,611
SprycelDasatinib14420$236,170
JakafiRuxolitinib Phosphate11330$158,656
PromactaEltrombopag Olamine12360$78,681
EliquisApixaban15450$10,090

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$464E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.11$508,685BeiGene, Ltd.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nurul Abul Wahid, M.D.?

Tedicare shows public-source Medicare data for Nurul Abul Wahid, M.D. (NPI 1508808619), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nurul Abul Wahid, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nurul Abul Wahid, M.D.?

Nurul Abul Wahid, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Nurul Abul Wahid, M.D. have Open Payments data?

Nurul Abul Wahid, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.